Subtype
Lung Carcinoma
CI-CAN-00001086Explore in graph →
2,130 active trials51 approved drugs598 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001086Explore in graph →
Clinical trials
7,791 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,177)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00908336 | Erlotinib and Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Failure of One Chemotherapy Regimen | unknown | Phase 2 | 70 | Hospital Arnau de VilanovaOTHER | 1 | May 25, 2009 | clinicaltrials |
| NCT00905983 | Biweekly Gemcitabine and Docetaxel as First Line Treatment for Advanced Disease in Elderly Non-Small Cell Lung Cancer (NSCLC) Patients | unknown | Phase 2 | 48 | Hospital Arnau de VilanovaOTHER | 1 | May 21, 2009 |
| clinicaltrials |
| NCT00906061 | Biweekly Gemcitabine and Docetaxel as First Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients | unknown | Phase 2 | 76 | Hospital Arnau de VilanovaOTHER | 1 | May 21, 2009 | clinicaltrials |
| NCT00173524 | PharmacoEconomic Assessment IRESSA® in the Treatment of Non-Small-Cell Lung Cancer (NSCLC) | unknown | — | 200 | National Taiwan University HospitalOTHER | 1 | May 19, 2009 | clinicaltrials |
| NCT00903292 | Tailored Second Line Treatment by Epidermal Growth Factor Receptor (EGFR) Mutation in Patients With Advanced Lung Adenocarcinoma | unknown | N/A | 52 | National Cheng-Kung University HospitalOTHER | 1 | May 18, 2009 | clinicaltrials |
| NCT00465491 | Study of Picoplatin Efficacy After Relapse(SPEAR) | unknown | Phase 3 | 399 | Poniard PharmaceuticalsINDUSTRY | 15 | Apr 14, 2009 | clinicaltrials |
| NCT00722969 | Erlotinib and Sorafenib in Chemonaive Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer | unknown | Phase 2 | 48 | Universitair Ziekenhuis BrusselOTHER | 1 | Mar 3, 2009 | clinicaltrials |
| NCT00845143 | Vibration Response Imaging (VRI) in the Preoperative Management in Patients With Non-Small Cell Lung Cancer | unknown | — | 100 | Heidelberg UniversityOTHER | 0 | Feb 18, 2009 | clinicaltrials |
| NCT00846443 | Study of Concurrent Pemetrexed, Cisplatin and Radiotherapy in Local Advanced Non-Small Cell Lung Cancer | unknown | Phase 1 | 12 | Fudan UniversityOTHER | 1 | Feb 18, 2009 | clinicaltrials |
| NCT00270582 | A Study of Weekly Docetaxel Plus Cisplatin Followed by Gemcitabine vs. Gemcitabine Plus Cisplatin Followed by Weekly Docetaxel in the Treatment of Advanced Non-Small-Cell Lung Cancer | unknown | Phase 2 | 58 | Far Eastern Memorial HospitalOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00828022 | Measles Vaccine in Patients With Measles Virus-Positive, Advanced Non-Small Cell Lung Cancer(SMC4692) | unknown | Phase 1 / Phase 2 | 15 | Soroka University Medical CenterOTHER | 1 | Jan 23, 2009 | clinicaltrials |
| NCT00815971 | Mutations in the Epidermal Growth Factor Receptor(EGFR) Gene in Non-Small Cell Lung Carcinoma (NSCLC) and the Relation to Response of Treatment With Erlotinib | unknown | — | 300 | Aarhus University HospitalOTHER | 1 | Dec 31, 2008 | clinicaltrials |
| NCT00497250 | Phase I Study of Iressa and CRT/IMRT in Chinese Patients With IIIB/IV NSCLC After Failure of Platinum-Based Chemotherapy | unknown | Phase 1 | 32 | Fudan UniversityOTHER | 1 | Oct 21, 2008 | clinicaltrials |
| NCT00546130 | Feasibility Study of CDDP + CPT-11 + PSK for Extensive-Stage Disease (ED) Small Cell Lung Cancer(RNCLC) | unknown | Phase 2 | 45 | University of ToyamaOTHER | 1 | Sep 3, 2008 | clinicaltrials |
| NCT00727350 | Protocol for Primary Fractionated Stereotactic Body Radiation Therapy for Stage T1 - T3N0 Non Small Cell Lung Carcinoma. | unknown | Phase 2 | 44 | Universitair Ziekenhuis BrusselOTHER | 1 | Aug 4, 2008 | clinicaltrials |
| NCT00184964 | Validation of Coregistered CT-PET Imaging in Determining Tumor Volume and Atelectasis in Patients With Operable Non-Small-Cell Lung Cancer and Tumor Associated Atelectasis | unknown | N/A | 15 | Radboud University Medical CenterOTHER | 1 | Jun 4, 2008 | clinicaltrials |
| NCT00273494 | Neoadjuvant Chemotherapy Plus/Minus Surgery in Non-Small-Cell Lung Cancer (NSCLC) Stage IIIA/N2 | unknown | Phase 3 | 406 | Rigshospitalet, DenmarkOTHER | 1 | May 22, 2008 | clinicaltrials |
| NCT00678964 | Erlotinib Versus Carboplatin/Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)(TIE) | unknown | Phase 2 | 260 | LungenClinic GrosshansdorfOTHER | 1 | May 16, 2008 | clinicaltrials |
| NCT00673777 | Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer | unknown | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | May 14, 2008 | clinicaltrials |
| NCT00674258 | Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer | unknown | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | May 14, 2008 | clinicaltrials |
| NCT00663689 | Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung Cancer | unknown | Phase 2 | 45 | Guangdong Provincial People's HospitalOTHER | 0 | Apr 22, 2008 | clinicaltrials |
| NCT00379717 | Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) | unknown | Phase 1 / Phase 2 | 30 | Universitair Ziekenhuis BrusselOTHER | 1 | Mar 13, 2008 | clinicaltrials |
| NCT00319800 | Second-Line Irinotecan or Gefitinib in Docetaxel Pretreated NSCLC | unknown | Phase 2 | 50 | Gachon University Gil Medical CenterOTHER | 1 | Mar 12, 2008 | clinicaltrials |
| NCT00625352 | Study of Developing an Optimal Gemcitabine Based Regimen to Treat Elderly Patients With Advanced Non-Small Cell Carcinoma | unknown | Phase 2 | 48 | Ulsan University HospitalOTHER | 1 | Feb 28, 2008 | clinicaltrials |
| NCT00614809 | Efficacy of Gefitinib for Brain Metastasis of Non-Small Cell Lung Cancer | unknown | Phase 2 | 45 | Guangdong Provincial People's HospitalOTHER | 0 | Feb 22, 2008 | clinicaltrials |
| NCT00466089 | Study of 3D Radiotherapy With or Without Erlotinib (Tarceva®) in Patients With Localized Non-Small Cell Lung Cancer | unknown | Phase 2 | 90 | Hospital of NavarraOTHER | 1 | Jan 10, 2008 | clinicaltrials |
| NCT00561054 | Efficacy and Safety of Cetuximab in Combination With Cisplatin Gemcitabine as First-Line Therapy in Advanced NSCLC(Coimbra) | unknown | Phase 2 | 47 | Grupo Portugues de Estudo do Cancro do PulmaoOTHER | 1 | Nov 20, 2007 | clinicaltrials |
| NCT00466284 | Phase II Trial of Tarceva in Patients With Non-Small Cell Lung Cancer | unknown | Phase 2 | 46 | Grupo Gallego de Cancer de PulmonOTHER | 1 | Apr 27, 2007 | clinicaltrials |
| NCT00192829 | Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma | unknown | — | 100 | Rambam Health Care CampusOTHER | 1 | Apr 11, 2007 | clinicaltrials |
| NCT00425022 | VATS Lobectomy for Clinical Stage IB or II Lung Cancer | unknown | Phase 2 | 40 | National Cancer Center, KoreaOTHER_GOV | 1 | Jan 30, 2007 | clinicaltrials |
| NCT00062907 | Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer | unknown | Phase 1 | 9 | Corixa CorporationINDUSTRY | 1 | Dec 6, 2006 | clinicaltrials |
| NCT00168883 | Study for Patients With Non Small Cell Lung Cancer (NSCLC) | unknown | Phase 2 | 80 | Charite University, Berlin, GermanyOTHER | 1 | Nov 1, 2006 | clinicaltrials |
| NCT00364663 | The Utility and Cost-Effectiveness Analysis of 18F-FDG PETin Staging Potential Operable Non-Small Cell Lung Cancer | unknown | — | 100 | National Taiwan University HospitalOTHER | 1 | Aug 16, 2006 | clinicaltrials |
| NCT00339586 | First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene | unknown | Phase 2 | 40 | Universitair Ziekenhuis BrusselOTHER | 1 | Jun 21, 2006 | clinicaltrials |
| NCT00285675 | Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004 | unknown | Phase 2 | 25 | NovaceaINDUSTRY | 2 | May 31, 2006 | clinicaltrials |
| NCT00168922 | Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC) | unknown | Phase 2 | 50 | Charite University, Berlin, GermanyOTHER | 1 | Apr 27, 2006 | clinicaltrials |
| NCT00082472 | Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma (NSCLC) | unknown | Phase 1 / Phase 2 | 30 | ZivenaINDUSTRY | 1 | Apr 18, 2006 | clinicaltrials |
| NCT00268684 | Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC | unknown | Phase 3 | 381 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Feb 28, 2006 | clinicaltrials |
| NCT00168896 | A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage | unknown | Phase 2 / Phase 3 | 286 | Charite University, Berlin, GermanyOTHER | 1 | Feb 14, 2006 | clinicaltrials |
| NCT00265694 | Random Trial for Elderly Patients With NSCLC | unknown | Phase 3 | — | Inje UniversityOTHER | 1 | Dec 15, 2005 | clinicaltrials |
| NCT00150657 | Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer | unknown | Phase 2 | 45 | St. John Providence Health SystemOTHER | 1 | Nov 29, 2005 | clinicaltrials |
| NCT00173680 | Methylation Status of CD44 Promoter Region in Primary Lung Cancer | unknown | — | 40 | National Taiwan University HospitalOTHER | 1 | Nov 24, 2005 | clinicaltrials |
| NCT00155116 | SERPIN D1 and Its Role in Lung Cancer Invasion and Metastasis | unknown | — | 100 | National Taiwan University HospitalOTHER | 1 | Nov 23, 2005 | clinicaltrials |
| NCT00254319 | Previously Untreated Advanced Non-Small Cell Lung Cancer (NSCLC) | unknown | Phase 2 | — | The Cooper Health SystemOTHER | 1 | Nov 16, 2005 | clinicaltrials |
| NCT00238849 | Phase II Study of Oxaliplatin and Navelbine for Second-Line Treatment of Advanced NSCLC. | unknown | Phase 2 | 40 | Integrated Community Oncology NetworkOTHER | 1 | Oct 14, 2005 | clinicaltrials |
| NCT00040560 | Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer | unknown | Phase 1 | — | CopharosINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
Data updated 23 days agoSource updated May 25, 2009source: clinicaltrials